DelfaGLP-1 Atlas

← Trials/Trial dossier/NCT06795360

Not yet recruitingPhase NA

Weight Changes After Incretin-mimetics

Asset

GLP-1 / incretin class catch-all

Listed sites

0

Recruiting sites

—

Enrollment

52

estimated

Study population

Obesity / overweight

Key I/E criterion

—

Primary endpoints

•Body weight, absolute change (kg)•Fasting and post-prandial circulating AgRP

Identifiers

Registered as

NCT IDNCT06795360
Org study IDPRO00052666

Timeline

Milestones

Study first posted2025-01-28actual
Last update posted2026-02-24actual
Study start2026-12-01estimated
Primary completion2031-11-30estimated
Study completion2031-11-30estimated

Assets

Investigational agents

GLP-1 / incretin class catch-all

Study populations

Who this study enrolls

Obesity / overweight

Eligibility

Who can enroll

Minimum age18 Years
Maximum age50 Years
SexAll
Healthy volunteersNot accepted

Inclusion criteria

•adults 18 years or older
•men and women
•prescribed an incretin-mimetic for weight loss and for whom insurance coverage for this specific drug will lapse
•any ethnicity

Exclusion criteria

•weight > or = 400 lb
•type 1 or type 2 diabetes
•patients taking steroid medications
•anemia
•heart disease
•advanced kidney disease (CKD stage 4 and 5)
•decompensated liver disease
•hyperthyroidism
•untreated hypothyroidism
•active cancer
•post solid organ or bone marrow transplant
•HIV/AIDS
•pregnancy/plan for pregnancy in the next 6 months
•breastfeeding
•post-menopausal women
•current smoker
•current recreational drug use
•night shift or rotating shift workers

Endpoints (6)

What's being measured

Protocol endpoints and posted registry outcome measures, grouped into outcome categories. Composite endpoints show their component event types. Standard codes (LOINC, SNOMED CT) are shown where available.

Coverage by outcome category

Weight & body composition
3
Other (unclassified)
2
Patient-reported / QoL
1

Weight & body composition

3 endpoints
Primary/protocol endpoint

weight change

Time frame:3 months

Body weight, absolute change (kg)

change from baseline, improvement

Secondary/protocol endpoint/low confidence

RMR adaptation

Time frame:3 months

change from baseline, descriptive

Secondary/protocol endpoint

body composition

Time frame:3 months

Total fat mass

change from baseline, improvement

Patient-reported / QoL

1 endpoint
Secondary/protocol endpoint

subjective hunger ratings

Time frame:3 months

change from baseline, improvement

Other (unclassified)

2 endpoints
Primary/protocol endpoint/low confidence

fasting and post-prandial circulating AgRP

Time frame:3 months

change from baseline, descriptive

Secondary/protocol endpoint/low confidence

resting metabolic rate (RMR)

Time frame:3 months

change from baseline, descriptive

Provenance

Sources

Trial identity, design, statusClinicalTrials.gov API v2
Snapshot dateJuly 1, 2026
Endpoint classificationDelfa endpoint taxonomy v2 (May 13, 2026)
Results tableno registry results posted yet

Trial facts come from public ClinicalTrials.gov records. Endpoint categories are Delfa's classification of those records, not a ClinicalTrials.gov field. All figures reflect the July 1, 2026 snapshot.